Ursula Rochau, MD, MSc
Senior Scientist
UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and HTA, Department of Public Health and HTA/ ONCOTYROL - Center for Personalized Cancer Medicine, Area 4 HTA and Bioinformatics
Department of Public Health and Health Technology Assessment
Eduard Wallnoefer Center 1/ Innrain 66a
Hall in Tyrol/ Innsbruck
Austria
6060/ 6020
Papers:
CHRONIC MYELOID LEUKEMIA TREATMENT: STARTING WITH A HIGHLY POTENT TYROSINE KINASE INHIBITOR AND EARLY SWITCHING TO IMATINIB?